0FA0.L - Melexis NV

LSE - LSE Prezzo differito. Valuta in EUR.
73,89
+1,59 (+2,21%)
Alla chiusura: 06:45PM BST
Il grafico dei titoli non è supportato dal tuo browser attuale
Chiusura precedente72,29
Aperto73,35
DenaroN/D x N/D
LetteraN/D x N/D
Min-Max giorno73,35 - 73,95
Intervallo di 52 settimane73,35 - 73,95
Volume452
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)1,31
Rapporto PE (ttm)N/D
EPS (ttm)N/D
Prossima data utiliN/D
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    Melexis Q1 2023 results – First quarter sales of 228.6 million EUR

    Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - April 26th, 2023, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: www.melexis.com/en/news/2023/financial/melexis-q1-2023-results Attachment PR_ENG_Melexis_Q1 2023

  • GlobeNewswire

    Melexis Q4 and FY 2022 results – Full year sales of 836.2 million EUR

    Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - February 1, 2023, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: www.melexis.com/en/news/2023/financial/melexis-q4-and-fy-2022-results Attachment PR_ENG_Melexis_Q4 FY 2022

  • GlobeNewswire

    Melexis Q3 2022 results – Third quarter sales of 219.8 million EUR

    Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - October 26th, 2022, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: www.melexis.com/en/news/2022/financial/melexis-q3-2022-results Attachment PR_ENG_Melexis_Q3 2022

  • GlobeNewswire

    Melexis Q2 2022 results – Second quarter sales of 208.4 million EUR

    Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - July 27th, 2022, 07.00 hrs CET Dear, Please find herewith the link to our most recent press release: www.melexis.com/en/news/2022/financial/melexis-q2-2022-results Attachment PR_ENG_Melexis_Q2 2022